SCHEMBL4670637

SCHEMBL4670637

O=C(c1cccs1)C(CC1CCNCC1)C1CCNCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.39
CES1 P23141 2/20 0.39
KEAP1 Q14145 1/20 0.39
RAB9A P51151 6/20 0.39
NPC1 O15118 5/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 6/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
CPN1 P15169 1/20 0.37
CPB2 Q96IY4 1/20 0.37
TSHR P16473 3/20 0.37
HSD17B10 Q99714 1/20 0.37
HDAC3 O15379 2/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC2 Q92769 2/20 0.36
CACNA2D1 P54289 1/20 0.36
HPGD P15428 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4670634 0.75 RAB9A (0.40) CES2CES1KEAP1RAB9ANPC1
SCHEMBL4673078 0.74 CES2 (0.42) CES2CES1CPN1CPB2CYP2C19
SCHEMBL4676045 0.74 MEN1 (0.40) CES2CES1RAB9ANPC1ALDH1A1
SCHEMBL4672734 0.73 CPN1 (0.39) CPN1CPB2HDAC1HDAC2
SCHEMBL4674068 0.72 SLC6A2 (0.40) RAB9ANPC1MEN1KMT2ACYP2D6
SCHEMBL9049032 0.71 RAB9A (0.51) CES2CES1KEAP1RAB9ANPC1
SCHEMBL229300 0.69 ALDH1A1 (0.51) CES2CES1RAB9ANPC1ALDH1A1
SCHEMBL1877298 0.68 CES2 (0.44) CES2CES1RAB9ANPC1ALDH1A1
Hydrochloric Acid SCHEMBL228752 0.68 ALDH1A1 (0.50) CES2CES1RAB9ANPC1ALDH1A1
Bromide SCHEMBL10964629 0.68 ALDH1A1 (0.50) CES2CES1RAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899324-A2 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS Theravance, Inc. (US) 2008-03-19 EP disclosed
WO-2006127815-A2 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS THERAVANCE, INC. (US) 2006-11-30 WO disclosed